202 related articles for article (PubMed ID: 24052802)
1. When host defense goes awry: Modeling sepsis-induced immunosuppression.
Hu SB; Zider A; Deng JC
Drug Discov Today Dis Models; 2012; 9(1):e33-e38. PubMed ID: 24052802
[TBL] [Abstract][Full Text] [Related]
2. Molecular and cellular aspects of sepsis-induced immunosuppression.
Wang TS; Deng JC
J Mol Med (Berl); 2008 May; 86(5):495-506. PubMed ID: 18259721
[TBL] [Abstract][Full Text] [Related]
3. The Role of IFN-β during the Course of Sepsis Progression and Its Therapeutic Potential.
Rackov G; Shokri R; De Mon MÁ; Martínez-A C; Balomenos D
Front Immunol; 2017; 8():493. PubMed ID: 28533774
[TBL] [Abstract][Full Text] [Related]
4. Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis.
Cao C; Yu M; Chai Y
Cell Death Dis; 2019 Oct; 10(10):782. PubMed ID: 31611560
[TBL] [Abstract][Full Text] [Related]
5. Loss of suppression of tumorigenicity 2 (ST2) gene reverses sepsis-induced inhibition of lung host defense in mice.
Hoogerwerf JJ; Leendertse M; Wieland CW; de Vos AF; de Boer JD; Florquin S; van der Poll T
Am J Respir Crit Care Med; 2011 Apr; 183(7):932-40. PubMed ID: 20959556
[TBL] [Abstract][Full Text] [Related]
6. Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression.
Wang Z; Pu Q; Lin P; Li C; Jiang J; Wu M
J Vis Exp; 2019 Jun; (148):. PubMed ID: 31259890
[TBL] [Abstract][Full Text] [Related]
7. New perspectives on immunomodulatory therapy for bacteraemia and sepsis.
Opal SM
Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S70-3. PubMed ID: 21129935
[TBL] [Abstract][Full Text] [Related]
8. Distinct pathophysiologic mechanisms of septic acute kidney injury: role of immune suppression and renal tubular cell apoptosis in murine model of septic acute kidney injury.
Lee SY; Lee YS; Choi HM; Ko YS; Lee HY; Jo SK; Cho WY; Kim HK
Crit Care Med; 2012 Nov; 40(11):2997-3006. PubMed ID: 22878677
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-155 attenuates late sepsis-induced cardiac dysfunction through JNK and β-arrestin 2.
Zhou Y; Song Y; Shaikh Z; Li H; Zhang H; Caudle Y; Zheng S; Yan H; Hu D; Stuart C; Yin D
Oncotarget; 2017 Jul; 8(29):47317-47329. PubMed ID: 28525390
[TBL] [Abstract][Full Text] [Related]
10. Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression.
McBride MA; Patil TK; Bohannon JK; Hernandez A; Sherwood ER; Patil NK
Front Immunol; 2020; 11():624272. PubMed ID: 33613563
[TBL] [Abstract][Full Text] [Related]
11. Ketoprofen impairs immunosuppression induced by severe sepsis and reveals an important role for prostaglandin E2.
Brogliato AR; Antunes CA; Carvalho RS; Monteiro AP; Tinoco RF; Bozza MT; Canetti C; Peters-Golden M; Kunkel SL; Vianna-Jorge R; Benjamim CF
Shock; 2012 Dec; 38(6):620-9. PubMed ID: 23143054
[TBL] [Abstract][Full Text] [Related]
12. Management of Sepsis-Induced Immunosuppression.
Venet F; Rimmelé T; Monneret G
Crit Care Clin; 2018 Jan; 34(1):97-106. PubMed ID: 29149944
[TBL] [Abstract][Full Text] [Related]
13. Ethyl pyruvate reverses development of Pseudomonas aeruginosa pneumonia during sepsis-induced immunosuppression.
Chen W; Lian J; Ye JJ; Mo QF; Qin J; Hong GL; Chen LW; Zhi SC; Zhao GJ; Lu ZQ
Int Immunopharmacol; 2017 Nov; 52():61-69. PubMed ID: 28863323
[TBL] [Abstract][Full Text] [Related]
14. Sepsis-induced immunoparalysis: mechanisms, markers, and treatment options.
Hamers L; Kox M; Pickkers P
Minerva Anestesiol; 2015 Apr; 81(4):426-39. PubMed ID: 24878876
[TBL] [Abstract][Full Text] [Related]
15. Sepsis induced immunosuppression: Implications for secondary infections and complications.
Sundar KM; Sires M
Indian J Crit Care Med; 2013 May; 17(3):162-9. PubMed ID: 24082613
[TBL] [Abstract][Full Text] [Related]
16. Potential Targets to Mitigate Trauma- or Sepsis-Induced Immune Suppression.
Bergmann CB; Beckmann N; Salyer CE; Hanschen M; Crisologo PA; Caldwell CC
Front Immunol; 2021; 12():622601. PubMed ID: 33717127
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of human ghrelin and growth hormone: Attenuation of immunosuppression in septic aged rats.
Zhou M; Yang WL; Aziz M; Ma G; Wang P
Biochim Biophys Acta Mol Basis Dis; 2017 Oct; 1863(10 Pt B):2584-2593. PubMed ID: 28115288
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory therapies in sepsis.
Kox WJ; Volk T; Kox SN; Volk HD
Intensive Care Med; 2000; 26 Suppl 1():S124-8. PubMed ID: 10786969
[TBL] [Abstract][Full Text] [Related]
19. Effect of Mesenchymal Stromal Cells on T Cells in a Septic Context: Immunosuppression or Immunostimulation?
Le Burel S; Thepenier C; Boutin L; Lataillade JJ; Peltzer J
Stem Cells Dev; 2017 Oct; 26(20):1477-1489. PubMed ID: 28747098
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.
Patil NK; Bohannon JK; Sherwood ER
Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
